(0)A61K:3/7:
IPC6
SECTION A - HUMAN NECESSITIES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
A61K
4/8
<<   >>   A61K031/505 - A61K031/80  

31
/ 505 Pyrimidines, e.g. uracil, quinazolone [2]  

31
/ 51 Thiamines, e.g. vitamin B1 [2]  

31
/ 515 Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital [2]  

31
/ 52 Purines; Xanthines, e.g. caffeine, theophylline [2]  

31
/ 525 Isoalloxazines, e.g. riboflavins, vitamin B2 [2]  

31
/ 53 having six-membered rings with three nitrogens as the only ring hetero atoms [2]  

31
/ 535 having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms [2]  

31
/ 54 having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms [2]  

31
/ 545 Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula, , e.g. cephalosporins [2,6]  

31
/ 55 having seven-membered rings [2]  

31
/ 555 containing heavy metals [2]  

31
/ 557 Prostaglandins or analogues thereof, e.g. carbocyclins, prostacyclins, heteroprostaglandins [3]  

31
/ 56 Compounds containing cyclopenta[a]hydrophenanthrene ring systems, including ring-modified steroids, e.g. lanolin, nor- or homo-steroids [4]  

31
/ 565 not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane [2]  

31
/ 57 substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane [2]  

31
/ 575 substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane [2]  

31
/ 58 containing heterocyclic rings [2]  

31
/ 585 containing lactone rings [2]  

31
/ 59 Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems, e.g. vitamin D2, "activated ergosterol", ergocalciferol, cholecalciferol, antirachitic vitamin [2]  

31
/ 595 with vitamin A compound (fish liver extract A 61 K 35/60) [2]  

31
/ 60 Salicylic acid; Derivatives thereof, e.g. aspirin [2]  

31
/ 605 with additional oxy compounds [2]  

31
/ 61 with additional carboxylic acids, or esters or metal salts thereof [2]  

31
/ 615 with additional amines or amides [2]  

31
/ 62 with additional heterocyclic compounds [2]  

31
/ 625 having heterocyclic substituents [2]  

31
/ 63 Compounds containing para-N-benzene- sulfonyl-N-groups, e.g. sulfanilamide p-nitrobenzene-sulfonyl-hydrazone [2]  

31
/ 635 having a heterocyclic ring [2]  

31
/ 64 Sulfonylureas [2]  

31
/ 645 Compounds containing a ring system of three fused rings, having an amino or amino-alkylene radical attached to the central ring [2]  

31
/ 65 Tetracyclines [2]  

31
/ 655 Azo, diazo, azoxy, azido or diazoamino compounds [2]  

31
/ 66 Phosphorus compounds [2]  

31
/ 665 having oxygen as a ring hetero atom [2]  

31
/ 67 having sulfur as a ring hetero atom [2]  

31
/ 675 having nitrogen as a ring hetero atom [2]  

31
/ 68 Cobalamins, e.g. vitamin B12, cyanocobalamin [2]  

31
/ 685 Amine salts of phosphorus acids, e.g. lecithin [2]  

31
/ 69 Boron compounds [2]  

31
/ 695 Silicon compounds [2]  

31
/ 70 Carbohydrates; Derivatives thereof (A 61 K 31/68 takes precedence) [2]  

31
/ 705 Compounds containing cyclopenta[a]hydro- phenanthrene ring systems including ring-modified steroids, e.g. digitalis [4]  

31
/ 71 Fermentates, e.g. streptomycin; Such compounds synthetically prepared; Derivatives thereof [2]  

31
/ 715 Polysaccharides [2]  

31
/ 72 Ethers; Esters [2]  

31
/ 725 containing acid groups, e.g. heparin, agar-agar, pectin [2]  

31
/ 73 containing amino groups (A 61 K 31/725 takes precedence) [4]  

31
/ 735 containing substituents not provided for in groups A 61 K 31/72 to A 61 K 31/73 [2]  

31
/ 74 Synthetic polymeric materials [2]  

31
/ 745 Polymers of hydrocarbons [2]  

31
/ 75 of ethene [2]  

31
/ 755 Polymers containing halogen [2]  

31
/ 76 of vinyl chloride [2]  

31
/ 765 Polymers containing oxygen [2]  

31
/ 77 of oxiranes [2]  

31
/ 775 Phenolic resins [2]  

31
/ 78 of acrylic acid or derivatives thereof [2]  

31
/ 785 Polymers containing nitrogen [2]  

31
/ 79 of vinyl pyrrolidone [2]  

31
/ 795 Polymers containing sulfur [2]  

31
/ 80 Polymers containing hetero atoms not provided for in groups A 61 K 31/755 to A 61 K 31/795 [2]  

<< >>
1 4 8